Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Jinhai International Group Holdings Limited ( (HK:2225) ) has shared an update.
Jinhai Medical Technology Limited has entered into a five-year cooperation framework agreement with Ningbo Verykind Medical Device Co., Ltd., a subsidiary of David Medical Group, to collaborate on endoscope products for international markets. This partnership aims to enhance product delivery efficiency, cost competitiveness, and global academic influence through resource optimization and international certifications. The agreement is expected to broaden Jinhai’s income stream and align with its development strategy, ultimately benefiting shareholders.
More about Jinhai International Group Holdings Limited
Jinhai Medical Technology Limited operates in the medical technology industry, focusing on the manufacturing of minimally invasive surgery medical products. The company is engaged in international cooperation to expand its market reach and enhance its product offerings.
Average Trading Volume: 3,820,832
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$7.34B
For an in-depth examination of 2225 stock, go to TipRanks’ Overview page.